Evidence map›Paper›PMID 39815103›Full record

ReviewNature methods2025

Probing the physical hallmarks of cancer.

Hadi T Nia, Lance L Munn, Rakesh K Jain

Abstract readReview
In one paragraph

Review in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Understanding and targeting the tumour matrisome.Nature reviews. Clinical oncology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Metabolic starvation-induced cell swelling drives solid stress in tumors.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. PIEZO2 in tumors: from mechanobiological switches to activity-targeted therapies.Journal of experimental & clinical cancer research : CR · 2025
    Review
  15. Article
  16. Article
  17. A tale of tumors.Nature methods · 2025
    Article
  18. Article
  19. Solid Stress Estimations via Intraoperative 3D Navigation in Patients with Brain Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  20. [Multidimensional characteristics of the tumor microenviron-ment and advances in targeted delivery strategies].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadi T NiaDepartment of Biomedical Engineering, Boston University, Boston, MA, USA. htnia@bu.edu.ORCID http://orcid.org/0000-0003-1970-9901
Lance L MunnSteele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. lmunn@mgh.harvard.edu.
Rakesh K JainSteele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. rjain@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-7571-3548

Funding

Dissecting Pediatric Brain Tumor Microenvironment to Improve TreatmentR35CA197743 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2015 to 2020
$5.7M
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistanceU01CA261842 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K., MUNN, LANCE L. · 2021 to 2025
$3.1M
Reprogramming PDAC tumor microenvironment to improve immunotherapyU01CA224348 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BOUCHER, YVES, JAIN, RAKESH K. · 2017 to 2021
$2.9M
Probing functioning lung at the cellular resolution in health and diseaseDP2HL168562 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI NIA, HADI TAVAKOLI · 2022 to 2025
$2.5M
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolismR01CA259253 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K., VANDER HEIDEN, MATTHEW G. · 2021 to 2025
$2.3M
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatmentR01CA208205 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FUKUMURA, DAI, JAIN, RAKESH K. · 2017 to 2020
$2.2M
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastomaR01CA269672 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Rakesh K. Jain · 2022 to 2026
$1.9M
Classifying malignant pulmonary nodules using biophysics-enhanced artificial intelligenceR21EB031332 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI NIA, HADI TAVAKOLI · 2021 to 2021
$660k
Arnold and Mabel Beckman Foundation Beckman Young Investigator AwardBoston University (BU) Kilachand Fund AwardNCI NIH HHS R01 CA208205NCI NIH HHS R01 CA259253NCI NIH HHS R01 CA269672NCI NIH HHS R35 CA197743NCI NIH HHS U01 CA224348NCI NIH HHS U01 CA261842NSF | ENG/OAD | Division of Civil, Mechanical and Manufacturing Innovation (CMMI) CAREERU.S. Department of Defense (United States Department of Defense) HT9425241053U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP2HL168562U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32-CA216944U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-CA204949U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-CA208205U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-CA259253U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-HL128168U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-NS118929U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21EB031332U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35-CA197743U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01-CA 224348U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01-CA261842
6 · The paper itself

Abstract

The physical microenvironment plays a crucial role in tumor development, progression, metastasis and treatment. Recently, we proposed four physical hallmarks of cancer, with distinct origins and consequences, to characterize abnormalities in the physical tumor microenvironment: (1) elevated compressive-tensile solid stresses, (2) elevated interstitial fluid pressure and the resulting interstitial fluid flow, (3) altered material properties (for example, increased tissue stiffness) and (4) altered physical micro-architecture. As this emerging field of physical oncology is being advanced by tumor biologists, cell and developmental biologists, engineers, physicists and oncologists, there is a critical need for model systems and measurement tools to mechanistically probe these physical hallmarks. Here, after briefly defining these physical hallmarks, we discuss the tools and model systems available for probing each hallmark in vitro, ex vivo, in vivo and in clinical settings. We finally review the unmet needs for mechanistic probing of the physical hallmarks of tumors and discuss the challenges and unanswered questions associated with each hallmark.

Indexed as

NeoplasmsTumor MicroenvironmentAnimalsExtracellular FluidHumansModels, BiologicalStress, Mechanical

Identifiers

PMID39815103
PMCPMC13003409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.